MGAM and Cirrhosis: In AKI patients with cirrhosis, the upregulation of maltase–glucoamylase (MGAM), a renal brush border disaccharidase, in urinary exosomes has also been suggested as a potential biomarker, which may differentiate the type of kidney injury in cirrhosis.